Abstract |
MTW9-D, a rat mammary tumor derived from MTW9 by chronic administration of the dopamine antagonist drug R33,812 shows ovariectomy-induced regression (OIR). MTW9-MtT is also a variant of MTW9, grown by coimplantation of a mammosomatotropic tumor MtTW10, but it does not show OIR. However, when the mammosomatotropic tumor (MtT) is resected, the tumor regresses and shows rapid OIR; implantation of MtT into animals bearing MTW9-D prevents OIR following drug withdrawal. The estradiol receptor (ER) from MTW9-D cytosol binds to DNA-cellulose significantly more than that from MTW9-MtT. After MtT resection, the mammary tumor ER binds to DNA-cellulose, as well as ER from MTW9-D, whereas implantation of MtT into animals bearing MTW9-D decreases ER binding to DNA-cellulose. The significance of these findings in relation to possible clinical application is discussed.
|
Authors | S Khan, M Feldman, V P Hollander |
Journal | Cancer research
(Cancer Res)
Vol. 40
Issue 4
Pg. 1050-3
(Apr 1980)
ISSN: 0008-5472 [Print] United States |
PMID | 7357535
(Publication Type: Comparative Study, Journal Article, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Receptors, Estrogen
- Estradiol
- Prolactin
- DNA
|
Topics |
- Animals
- Castration
- DNA
(metabolism)
- Estradiol
(metabolism)
- Female
- In Vitro Techniques
- Mammary Neoplasms, Experimental
(metabolism, therapy)
- Neoplasms, Experimental
(metabolism)
- Neoplasms, Hormone-Dependent
(metabolism)
- Prolactin
(metabolism, physiology)
- Rats
- Rats, Inbred WF
- Receptors, Estrogen
(metabolism)
|